METHUSELAH ARCHIVE SOURCES / PAULING-RATH-PATENT-US5278189A-1994

Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (a)

primary document · 1994
type:primary document
year:1994
citation:Rath MW, Pauling LC. Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (a). US Patent 5,278,189 A. Filed 24 July 1990; granted 11 January 1994.
LINK
https://patents.google.com/patent/US5278189A/en
SUMMARY
US Patent 5,278,189A, co-invented by Linus Pauling and Matthias Rath, claiming a method of treating and preventing occlusive cardiovascular disease with a composition of ascorbate (vitamin C) plus lipoprotein(a)-binding inhibitors such as lysine. Filed 24 July 1990, granted 11 January 1994 -- seven months before Pauling's death (19 August 1994). Original assignee of record: Therapy 2000, a California corporation; current assignee of record: Matthias Rath Holding BV. Patent title, inventors, filing/grant dates, and assignee chain all read directly from the Google Patents record (a mirror of the USPTO grant record).
NOTES

Direct documentary evidence that Pauling sought commercial, patent-protected rights over a vitamin C therapeutic claim, assigned to a corporation, rather than merely publishing open scientific findings — the clearest available record of the case’s financial-conflict dimension.